Asasantin ER

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Healthy

Phase 1

Tolerability of Asasantin in Healthy Female and Male Subjects

CompletedNCT02269228

Boehringer IngelheimHealthy

Start: 2000-02-29Updated: 2014-10-21

Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects

CompletedNCT02273492

Boehringer IngelheimHealthy

Start: 1999-08-31Updated: 2014-10-24